BrainEver
France - ParisBiotechnology
Focus: BrainEver is a French biotechnology company founded in 2005 specializing in therapies for neurodegenerative diseases, with a public listing and focus on the neurology market.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About BrainEver
AI assessmentNot HiringNo open roles listed right now. Follow BrainEver to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Evaluation of Clinical Progression in Patients With Motor Predominant Parkinson Disease.
Parkinson DiseaseClinical Trials (1)
NCT03960242Evaluation of Clinical Progression in Patients With Motor Predominant Parkinson Disease.
N/AHelp build intelligence for BrainEver
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.